As of 2026-05-26, the EV/EBITDA ratio of Caplin Point Laboratories Ltd (CAPLIPOINT.NS) is 16.63. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CAPLIPOINT.NS's latest enterprise value is 151,523.38 mil INR. CAPLIPOINT.NS's TTM EBITDA according to its financial statements is 9,112.10 mil INR. Dividing these 2 quantities gives us the above CAPLIPOINT.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 17.3x | 16.5x |
| Forward P/E multiples | 9.1x - 11.8x | 10.0x |
| Fair Price | 1,143.35 - 2,155.96 | 1,657.76 |
| Upside | -45.0% - 3.8% | -20.2% |
| Date | EV/EBITDA |
| 2026-05-22 | 16.21 |
| 2026-05-21 | 16.20 |
| 2026-05-20 | 16.11 |
| 2026-05-19 | 16.31 |
| 2026-05-18 | 15.87 |
| 2026-05-15 | 16.05 |
| 2026-05-14 | 16.18 |
| 2026-05-13 | 14.57 |
| 2026-05-12 | 14.52 |
| 2026-05-11 | 14.71 |
| 2026-05-08 | 14.78 |
| 2026-05-07 | 14.82 |
| 2026-05-06 | 14.69 |
| 2026-05-05 | 13.71 |
| 2026-05-04 | 13.82 |
| 2026-04-30 | 13.52 |
| 2026-04-29 | 13.64 |
| 2026-04-28 | 13.72 |
| 2026-04-27 | 13.97 |
| 2026-04-24 | 13.61 |
| 2026-04-23 | 14.07 |
| 2026-04-22 | 13.92 |
| 2026-04-21 | 13.89 |
| 2026-04-20 | 13.86 |
| 2026-04-17 | 14.00 |
| 2026-04-16 | 14.05 |
| 2026-04-15 | 13.64 |
| 2026-04-13 | 13.35 |
| 2026-04-10 | 13.54 |
| 2026-04-09 | 13.12 |
| 2026-04-08 | 13.17 |
| 2026-04-07 | 12.70 |
| 2026-04-06 | 12.40 |
| 2026-04-02 | 12.41 |
| 2026-04-01 | 12.41 |
| 2026-03-30 | 11.82 |
| 2026-03-27 | 12.30 |
| 2026-03-25 | 12.60 |
| 2026-03-24 | 12.59 |
| 2026-03-23 | 12.34 |
| 2026-03-20 | 12.72 |
| 2026-03-19 | 12.83 |
| 2026-03-18 | 12.98 |
| 2026-03-17 | 12.93 |
| 2026-03-16 | 12.91 |
| 2026-03-13 | 13.14 |
| 2026-03-12 | 13.35 |
| 2026-03-11 | 13.35 |
| 2026-03-10 | 13.39 |
| 2026-03-09 | 13.22 |